Amgen opens new research, development site

Amgen, a biopharmaceutical company based in Thousand Oaks, Calif., unveiled its second largest new research and development facility in San Francisco Oct. 6. 

Advertisement

The 245,000 square foot, nine-story site will focus on researching treatments for cancer, inflammatory disease and cardiometabolic disorders, according to a news release from the company. Amgen said the new building will employ 650 people among 24 different functions.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.